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Abstract
Background Gastric electrical stimulation (GES) has been
proposed as a promising therapeutic option in treating obe-
sity for 20 years. Currently, the available device of GES
cannot meet the clinical needs. The purpose of this study is
to verify the effect of a new type of adjustable gastric elec-
trical stimulator in reducing food intake and body weight.
Methods Eight beagle dogs randomly followed GES and
sham GES for 3 months in a crossover design. Parameters
were adjusted and individualized during the experiment.
Symptoms of GES were recorded, and the effective param-
eters were selected. Resistance to GES was assessed. Food
intake and body weight were measured to evaluate the effect
of GES.
Results The effective parameters were varied among the dogs.
Resistance to GES was observed in different periods in dogs.
Parameters needed to be adjusted every 10.2±2.1 days during
the period of GES. Food intake during GES for 3 months was
significantly reduced than that during sham GES of 3 months
(P<0.05). With the decreased food intake, body weight was
significantly reduced by the end of GES of 3 months compared
with that of sham GES of 3 months (P<0.05).
Conclusions Food intake and body weight of dogs are sig-
nificantly reduced by adjustable GES. Individual parameters
and resistance during GES are required to be considered. The
new adjustable device may have good prospects of clinical
application for obesity.
Keywords Gastric electrical stimulation . Individual
parameter . Resistance . Obesity
Introduction
Obesity is prevalent worldwide. Various treatments are avail-
able for obesity, such as exercise, diet, drugs, and surgery.
However, there is a lack of ideal therapy for obesity [1, 2].
Gastric electrical stimulation (GES) has been considered as a
promising therapeutic option in treating obesity for approx-
imately 20 years [3–5]. This technique is performed through
two electrodes inserted into the distal stomach and connected
to a stimulator implanted in the abdominal wall. By deliver-
ing electrical pulses to the stomach, GES was reported to
alter gastric motility, inhibit appetite, and reduce body
weight [6–8]. The gastrointestinal anatomy is not affected
during the procedure of GES. GES is less invasive and a
safer method for treating obesity compared with bariatric
surgery [9–11].
There are several electrical stimulation methods which
involve long pulse stimulation, short pulse stimulation, and
stimulation with trains of pulses [12, 13]. Currently, GES
with trains of short pulses is mainly used in the clinical study
for obesity [14, 15]. These studies have been confined to the
use of GES with the following typical parameters: a pulse
width of 0.3 ms, an amplitude of 5–10 mA, a frequency of
40 Hz, and 2 s on–3 s off. The commercial implantable
devices of short pulses used in clinical studies have been
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mainly adapted from a cardiac or nerve stimulator [15–18].
After intensive investigation of GES, some of the following
problems must be considered: (1) Although the pulse
width <1 ms is enough for cardiac or nerve stimulation, short
pulses for GES may not be potent enough [19, 20]. (2) Based
on differences of individual sensitivity, adjustable parameters
are required in a wide range [21, 22]. (3) A fixed mode of
parameters is insufficient and not adequately maintained for
long-term use.
In collaboration with the Institute of Microelectronics of
Tsinghua University, we have developed a new type of
adjustable gastric electrical stimulator. This stimulator fea-
tures a pulse width of 0.3–10 ms, an amplitude of 1–10 mA,
a frequency of 40 Hz, and 2 s on–3 s off. The parameters of
this device are adjustable in line with stimulation, and the
battery can be remotely recharged.
In this study, a type of adjustable stimulator was applied to
produce chronic GES on beagle dogs. Parameters were ad-
justed and individualized according to demand during GES.
Resistance (i.e., diminution in the response to GES after
long-term use) was assessed. Food intake and body weight
were measured to evaluate the effect of GES.
Methods and Procedures
Animal Preparation and Surgical Procedure
Eight healthy female beagle dogs (Academy of Military
Medical Sciences) (8.5–13 kg) were involved in this study
and allowed an acclimation period of 2 weeks. After an over-
night fast, the dogs were anesthetized with a combination of
fentanyl (2μg/kg), propofol (2mg/kg), rocuronium (0.6mg/kg)
and maintained on 1–2 % sevoflurane in oxygen (1.0 L/min)
carrier gases delivered from a ventilator after endotracheal
intubation. Vital signs (respiratory rate, pulse, and tongue color)
were monitored. By laparoscopy, one pair of platinum–iridium
electrodes was sutured into the seromuscular layer along the
greater curvature of the stomach, 3.0 cm above the pylorus. The
electrodes were 1.0 cm apart. An adjustable electrical stimula-
tor (Noted Technology Development Co. Ltd., China) was
embedded under the costal margin of the right upper quadrant
subcutaneously and then secured in place by a purse-string
suture. After surgery, the dogs wore special jackets and were
allowed to recover in their individual cages. The room was
humidity and temperature controlled (20–22 °C) with a fixed
12–12-h light–dark cycle. The dogs had enough solid food at a
set time (5–7 pm daily) and had free access to water in their
home cages at all times. The postoperative situations including
swelling, secretions, ulcer, subcutaneous transposition, wound
healing, and exposed material were observed and recorded. All
experiments were performed after the dogs were completely
recovered, usually 2 weeks after the surgery.
The study was approved by the Animal Care and Use
Committee of China-Japan Friendship Hospital.
Symptoms
During the experiment, the situations of dogs including spirit,
vital signs, activities, and defecation frequency were recorded.
Evaluation of the dogs’ symptoms included licking with the
tongue, sialorrhea, vomiting, yawning, barking, groaning,
belching, murmuring, and dysphoria. These symptoms were
assessed based on their frequency and/or severity (0: never; 1:
seldom/mild; 2: often/moderate; 3: continues/severe). The
total symptom score of each dog was derived during the
experiment, and its correlation with the stimulation energy
was assessed. Based on our preliminary acute animal experi-
ment, resistance to GES was demonstrated. Symptoms were
recorded daily to explore the feature of resistance and to adjust
parameters. To make the evaluation objective, the person who
evaluated the signs was objective and blinded from the study
design.
Selection of Stimulation Parameters
The subcutaneous stimulator received stimulation signals
which were programmed by an external programmer
during the experiment. The periodic rectangular pulses
with an amplitude of 1–10 mA, a pulse width of 0.3–
10 ms, a frequency of 40 Hz, and 2 s on–3 s off were
delivered. After being completely recovered from the
surgery, each dog endured a selection period of pulse
width for 2 weeks, generally from small to large (0.3, 0.75,
1, 2, 3, 4, 5, 6, 7, 8, 9, and 10 ms), and simultaneously, the
other parameters were fixed relatively. During the selection
period, GES was applied for a whole day except that symptom
score was ≥3.
The selection of stimulation parameters was based on the
total symptom score. Intolerable parameters were recognized
when the total symptom score was ≥3. The maximum pulse
widths were selected which did not induce obvious symp-
toms (score <3). If the intolerable pulse width was ≤l.0 ms,
lower amplitude was chosen (3, 6, and 9 mA).
Food Intake and Weight
During the whole study period, food intake was mea-
sured daily, and fasting weight was recorded weekly.
The dogs were given >500 g of food (laboratory diet, protein
23.8 %, fat 8.4 %, fiber 2.9 %, 3.54 kcal/g). Food was
provided at a set time slot (5–7 pm). During the experiment,
GES or sham GES was practiced 1 h before food intake and
then continued for 3 h. The remaining food was removed at
the end of the stimulation period, and daily food consumption
was recorded.
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Experimental Protocol
The experiment followed a crossover trail. After the periods
of recovery and selection of the initial effective stimulation
parameters, the dogs were randomly studied in two groups:
in group A, four dogs underwent a 3-month treatment with
GES, a 2-week washout period, and a 3-month control with
sham GES sequentially. The other four dogs in group B
underwent the experiment in a reversed order. The proce-
dures for sham GES were the same as the GES procedures
except that the stimulators were not turned on. Parameters
were selected, individualized, and adjusted during the exper-
iment. The system impedance of each stimulator was
checked before and after the placement and then every week
throughout the study.
Statistical Analysis
All data were presented as mean ± SD. Differences in food
intake and body weight across GES and sham GES were
analyzed by crossover ANOVA. Differences of food intake
and body weight within groups were evaluated using repeat-
ed measures ANOVA. The level of statistical significance
was set at p<0.05.
Results
Symptoms
All dogs completed the study, and nonewas observed to display
severely abnormal behaviors during the application of GES.
Symptoms were not observed with sham GES. Symptoms of
every dog during higher-intensity GESwere different. Frequent
symptoms during GES included sialorrhea, vomiting, barking,
dysphoria, and licking with the tongue. During lower-intensity
GES, dogs did not display severe signs of discomfort.
Symptoms were adapted when the symptom score was 1–2.
Food intake was affected withmild symptoms duringGES. The
most intolerable symptoms included continued sialorrhea,
vomiting (which were observed in all of the dogs during the
higher-intensity GES), barking (in three dogs), and dysphoria
(in three dogs). The time for symptoms induced by GES to
appear varied among the dogs, ranging from 5 min to 1 h after
the operation of GES.
Selection of Parameters
1. Initial effective stimulation parameters (i.e., the maximum
pulse widths which did not induce obvious symptoms
(score<3)), which were lower than the initial intolerable
parameters, were adopted. Meanwhile, food intake could
be significantly reduced by the selected parameters.
2. Resistance was recognized as when an increase in food
intake after a period of GES was observed with initial
effective stimulation parameters. Subsequently, a decrease
in food intakewas observedwhen the stimulation intensity
was elevated with the extracorporeal programmer.
3. Resistance was induced by chronic GES. Resistance was
observed in different durations among the dogs. A
higher intensity of GES was given to the dogs every
10.2±2.1 days according to demand.
4. Effective and intolerable parameters varied greatly
among the dogs. A trend of individualized parameters
was clearly observed. The characteristics of GES param-
eters were summarized in Table 1.
The initial effective stimulation parameters included
the pulse widths of 0.5–1.0 ms and amplitudes of 3–
10 mA (with the pulse widths and amplitudes adjusted
and the other parameters fixed). The initial intolerable
parameters included the pulse widths of 0.75–3 ms and
amplitudes of 8–10 mA. The effective stimulation pa-
rameters of the later part of GES included the pulse
widths of 1–7 ms and amplitude of 10 mA.
5. The effects of stimulation were influenced by the pulse
width and amplitude. Dogs were more sensitive to the
pulse width than the amplitude. Seven dogs had adapted
the pulse width of 0.5 ms and the amplitude of 3–10 mA
at the parameter selection periods of GES. Symptom
score was 1–2. When the pulse width increased to
1 ms, the symptom score increased to three in four dogs.
Food Intake
Changes of food intake by GES and sham GES were showed
in Table 2. In group A, during the period of GES of 3 months,
significant decrease in average food intake was observed
with the individualized parameters (GES of 1 month vs.
post-surgery, P<0.05; GES of 3 months vs. post-surgery,
P<0.05). During the period of sham GES of 3 months, food
intake showed no significant difference compared with that
of post-surgery (sham GES of 1 month vs. post-surgery,
P>0.05; sham GES of 3 months vs. post-surgery, P>0.05).
In group B, during the period of sham GES of 3 months,
increase in food intake was statistically significant compared
with that of post-surgery (sham GES of 3 months vs. post-
surgery, P<0.05). During the period of GES of 3 months,
significant decrease in average food intake was observed
(GES of 1 month vs. post-surgery, P<0.05; GES of 3 months
vs. post-surgery, P<0.05).
The time profiles for changes on food intake were shown
in Fig. 1. The difference in food intake between GES and
sham GES was significant. Dogs with GES of 3 months ate
significantly less food than those with shamGES of 3 months
(P<0.05). Although the fluctuation was observed during GES
for 3 months, the trend of decreased food intake obviously
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existed. Moreover, dogs with GES ate less than they did after
surgery while dogs with sham GES did not modify their
overall food intake (group A) and continued to eat more than
that after surgery (group B).
Weight Evolution
In group A, during the period of GES of 3 months, especially
in the later part, significant decrease in body weight was
observed (GES of 3 months vs. post-surgery, P<0.05).
During the period of sham GES of 3 months, body weight
showed no significant difference compared with that of post-
surgery (sham GES of 3 months vs. post-surgery, P>0.05).
In group B, by the end of sham GES of 3 months, body
weight was increased significantly compared with that of
post-surgery (sham GES of 3 months vs. post-surgery,
P<0.05). During the period of GES of 3 months, with the
decrease in food intake, body weight was decreased com-
pared with that of post-surgery (GES of 3 months vs. post-
surgery, P<0.05). Changes of body weight by GES and
sham GES were shown in Table 2.
The difference on body weight of dogs between GES and
sham GES was statistically significant. Body weight by the
end of GES of 3 months was obviously decreased compared
with that of sham GES of 3 months (P<0.05). GES induced
Table 1 The individual parameters of GES for eight beagle dogs (pulse width (in millisecond)/amplitude (in milliampere))
Number 1 2 3 4 5 6 7 8
Initial effective parameters 0.5/10 0.5/3 0.5/3 0.5/6 0.5/4 1.0/10 0.5/8 0.5/5
Initial intolerable parameters 3/10 1/10 2/10 0.75/10 0.75/5 3.0/10 1.5/10 0.75/8
Effective parameters of the later part 4.0/10 1/10 3.0/10 4.0/10 2.0/10 7.0/10 4.0/10 3.0/10
Both the effective parameters and the intolerable parameters varied greatly among the dogs. A trend in individual variations was observed with
respect to the initial effective stimulation intensity, initial intolerable of stimulation intensity, and the intensity of the later part of stimulation
Table 2 Effect of GES and sham GES with individual parameters on
food intake (in gram) and body weight (in kilogram)





Post-surgery 279.3±14.9 11.2±1.0 214.0±8.8 8.8±0.7
GES 1 m 215.5±29.3* 10.6±1.1* 154.3±13.5* 9.1±0.5
GES 3 m 206.0±8.6* 10.4±1.1* 153.5±15.0* 7.8±0.3*
Sham GES 1 m 278.8±22.1 11.0±0.9 219.3±8.2 8.9±0.7
Sham GES 3 m 281.8±23.9 11.5±0.9 227.0±9.1* 9.4±0.6*
Changes of food intake and body weight by GES and sham GES. In
group A, during the period of GES of 3 months, significant decrease in
average food intake and body weight was observed (P<0.05 GES of
1 month vs. the post-surgery; P<0.05 GES of 3 months vs. the post-
surgery). In group B, at the end of sham GES of 3 months, increase in
food intake and body weight was significant compared with that of
post-surgery (P<0.05 GES of 3 months vs. the post-surgery). At the end
of GES of 3 months, significant decrease in average food intake and
body weight was observed (P<0.05 GES of 3 months vs. the post-
surgery)
*P<0.05 indicates statistical significance of differences from post-
surgery
Fig. 1 a Effect of GES and sham GES with individual parameters on
food intake of group A (in gram). b Effect of GES and sham GES with
individual parameters on food intake of group B (in gram). The differ-
ence in food intake between GES and sham GES was significant. Dogs
with GES of 3 months ate significantly less food than those with sham
GES of 3 months (P<0.05)
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weight loss while sham GES did not decrease body weight,
and the weight even continued to increase gradually during
the period of sham GES. The time profiles for changes in
body weight were shown in Fig. 2.
During the experiment, no adverse reactions were observed,
and the security of GES was indicated. The impedance was in
the range of 500–1,000Ω during the entire study period. These
values were within the normal range of electrode impedance.
Discussion
In the present study, using a new adjustable device, we found
the following: (1) Food intake and body weight of the dogs
were reduced significantly after the adjusted stimulation
intensity according to demand. (2) The response of dogs to
GES varied according to individual dogs. The pulse width of
the effective stimulation varied greatly. (3) Using chronic
GES, resistance to parameters was observed. Parameters
needed to be adjusted every 10.2±2.1 days during the period
of GES.
GES has been reported to reduce food intake and body
weight in animals and in human studies [15, 23]. A study
followed up 69 European obese patients and reported signif-
icant reductions in weight by GES [24]. However, in some
studies, a loss in excess body weight was not observed
[25–27]. A clinical trial with 103 patients in the USA report-
ed no greater weight loss at 7 months in those with the device
activated compared with those with sham stimulation [27].
The reasons for these differences in results between studies
using the same method are unclear.
Recently, more experiments have proved the importance
of pulse width in the stimulation process [28–30]. The pos-
sible mechanisms between expanded pulse width and re-
duced food intake or body weight have not been fully eluci-
dated. Pathways of mechanical, neuronal, and hormonal
systems have a close relation with GES in the regulation of
energy balance [31–33]. Studies have shown that the stom-
ach is composed of smooth muscle cells with a slow re-
sponse to electrical stimulation and that GES with short
pulses may not be potent enough to activate smooth muscles
and alter their function [19, 34]. Gastric slow waves were not
altered by GES with pulse width shorter than 1 ms [34]. GES
with a pulse width of 2 ms was found significantly decreased
liquid and solid gastric emptying in canines [29]. With an
increased pulse width, neuronal responses to GES were
strengthened [35]. Moreover, an increase in pulse width of
GES had the largest effect on ventral medial hypothalamic
neuronal activity, and these effects were paralleled by pulse
width-dependent reductions in food intake and body weight
[28]. One recent study also reported that expanded pulse
width GES increased oxytocin and decreased ghrelin in the
hypothalamus of rats [36]. Based on the relationship between
weight loss and pulse width, the recommended pulse width
would be >3 ms [28]. These studies support the notion that
GES with an expanded pulse width is an effective treatment
for obesity.
Individual parameters of GES have been rarely reported.
Data from clinical studies [21, 37] showed that there were
individual differences in visceral sensitivity. There was also
a wide diversity of visceral responses to GES among in-
dividuals. The inhibitory effects of GES on gastric function
were correlated with visceral sensitivity of the individual
[22]. Optimal parameters should be determined according
to the individual sensitivity to GES. Observation and evalu-
ation of visceral sensitivity could be used to screen patients
who need a long-term implantable GES. These studies indi-
cated that a fixed pattern of GES is not an ideal adoption, and
individual parameters are more effective. In our experiment,
the reaction of each dog to chronic GES was different. A
Fig. 2 a Effect of GES and sham GES with individual parameters on
body weight of group A (in kilogram). b Effect of GES and sham GES
with individual parameters on food intake of group B (in kilogram). The
difference in body weight between GES and sham GES was significant.
Body weight by the end of GES of 3 months was obviously decreased
compared with that of sham GES of 3 months (P<0.05)
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trend in individual variations was observed in respect to the
initial effective stimulation intensity, initial intolerable stim-
ulation intensity, and the intensity of the later part of stimu-
lation. Based on the factor of individual differences, effective
parameters were ensured for every dog by selection of pa-
rameters. This suggests that to improve the efficacy of GES,
the individualized choice of stimulation parameters is impor-
tant. Our results may explain why GES was ineffective for
some patients in previous clinical studies. Our findings also
indicate that, in addition to the need for screening parameters
for patients in further studies [31], selection and adjustment
of parameters should be based on individual symptoms to
GES (appetite, satiety, and discomfort) and food intake, to
achieve the optional stimulation effect.
In the present study, resistance was observed during GES.
In a previous canine study during ten consecutive days, food
intake and body weight were reduced by GES (375 ms,
6 cpm, and 4 mA) within a few days, while some weight
was regained during the latter stages of stimulation [38].
During our chronic GES study, stimulation parameters need-
ed to be adjusted every 10.2±2.1 days because of resistance.
After parameters were adjusted according to demand, inhib-
itory effects on food intake and body weight were observed
by increasing the intensity of stimulation. The initial effec-
tive stimulation pulse widths were 0.5 to 1.0 ms. The inten-
sity of stimulation was gradually increased with resistance.
The effective stimulation pulse widths of the later part of
GES were 1.0 to 7.0 ms. These pulse widths were wider than
the 0.3 ms applied in a previous clinical commercial device
[19]. Especially with prolongation of the stimulation time
and the appearance of resistance, a pulse width much greater
than 0.3 ms is required to inhibit feeding. These data may
explain why the use of GES with a pulse width of 0.3 ms
could not achieve the desired effects in all of the patients.
They also indicate that the effective stimulation intensity for
each individual varies. In addition, parameters should be
adjusted according to demand in the process of applying
GES. Therefore, the fixed stimulation parameter of <1.0 ms
pulse width for some individuals may be far less than the
effective stimulation intensity required.
A previous study reported that application of long pulse
retrograde gastric electrical stimulation (1.1 times the natural
frequency) reduced food intake and influenced the regularity
of gastric myoelectrical activity [39]. Obvious symptomswere
caused by high-intensity stimulation (550–950 ms, 6–9 mA),
while no obvious symptoms were caused by low-intensity
stimulation (550 ms, 3–4.5 mA). In the present study,
sialorrhea and vomiting were induced by high-intensity
GES, and no symptoms or otherwise mild symptoms were
induced by low-intensity GES. Therefore, symptoms have a
close relationship with stimulation intensity. In addition, pulse
width and amplitude influence the effect of stimulation.
Moreover, in our study, the dogs were more sensitive to pulse
width than amplitude. This result indicates that if dogs
appeared to be intolerable to the parameters, the pulse width
should be lowered first. Conversely, if the effect of stimulation
is not obvious, the pulse width should be raised first.
Amplitude can be relatively fixed. These results provide an
experimental basis for selecting GES parameters.
During the period of sham GES of 3 months, food intake
and body weight were significantly increased. This may have
resulted from postoperative recovery gradually and adaptation
after the intervention. Based on the crossover design, the con-
founding effects of the operation and the factor of time could be
ruled out. The inhibitory effects of GES on food intake and
body weight were well expressed by this study design.
Our study suggested that there were individual differences in
beagle dogs for GES. The effective pulse width of stimulation
had an extensive range. Resistance was found in all of the dogs.
Intermittent adjustment of stimulation parameters according to
demand, usually every 10.2±2.1 days, was required for long-
term application of GES. Although dogs are rarely obese, the
present study showed that food intake and body weight of dogs
were reduced by adjusting stimulation parameters and increas-
ing stimulation intensity by demand. These findings provide
experimental support for obesity treatment with GES in clinical
trials. Furthermore, in previous clinical studies, the time re-
quired to reduce weight by GESwas usually longer than 1 year.
Based on individual and adjustable parameters, the present
study indicated that the time required for observation of the
effect of GES might be reduced to 3–6 months.
In conclusion, this study may shed light on applying GES in
treating obesity. Individual parameters and resistance during
GES are required to be considered. Our new adjustable device
may have good prospects of clinical application for obesity.
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